2016
The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease
KHAZNEH, E.; P. HRIBOVA; J. HOSEK; Pavel SUCHÝ; Peter KOLLÁR et al.Základní údaje
Originální název
The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease
Autoři
KHAZNEH, E.; P. HRIBOVA; J. HOSEK; Pavel SUCHÝ; Peter KOLLÁR; G. PRAZANOVA; Jan MUSELÍK; Z. HANAKOVA; Jiří VÁCLAVÍK; M. MILEK; J. LEGATH a Karel ŠMEJKAL
Vydání
Molecules, BASEL, Mayer und Muller, 2016, 1420-3049
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.861
Označené pro přenos do RIV
Ne
Organizační jednotka
Farmaceutická fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Achillea wilhelmsii; anti-hypercholesterolemic; cardiometabolic disease; docking; flavonoids; 3-hydroxy-3-methylglutaryl-CoA reductase; hypoglycemic; inflammation
Změněno: 24. 2. 2021 14:15, PharmDr. Jitka Michlíčková
Anotace
V originále
This study was done to identify the content compounds of Achillea wilhelmsii (A. wilhelmsii) and to evaluate its hypoglycemic and anti-hypercholesterolemic activity and effect on inflammatory mediators. The extracts and fractions of A. wilhelmsii were thoroughly analyzed using high performance liquid chromatography (HPLC), and the total content of phenols and flavonoids was determined. The hypoglycemic activity was evaluated in vivo using alloxan-induced diabetic mice. The effect upon inflammatory mediators was evaluated in vitro using the human monocytic leukemia cell line (THP-1). The anti-hypercholesterolemic activity was evaluated in vitro using the 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase assay kit. The water extract (WE)-treated group showed the highest reduction in the fasting blood glucose levels (FBGL). The chloroform fraction (CF) and ethyl acetate fraction (EAF) both showed a significant ability to reduce the secretion of tumor necrosis factor alpha (TNF-alpha). The EAF, however, also attenuated the levels of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). The CF showed the most significant 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibition activity. The five main compounds in the CF were isolated and identified. Out of the five compounds in the CF, 1 beta,10 beta-epoxydesacetoxymatricarin (CP1) and leucodin (CP2) showed the highest anti-hypercholesterolemic potential. A molecular docking study provided corresponding results.